Politico July 31, 2024
Gregory Svirnovskiy, Toni Odejimi, Carmen Paun, Daniel Payne, Ruth Reader and Erin Schumaker

WORLDVIEW

The possibility of an avian flu pandemic is driving a World Health Organization initiative to arm low- and middle-income countries with the technology and expertise to develop their own mRNA vaccines.

A virus is currently decimating world poultry populations and threatening to sicken humans.

On Monday, the WHO launched the new vaccine campaign alongside Argentina’s Sinergium Biotech.

How it works: Sinergium, which has already developed several candidate vaccines, will share relevant information with participating vaccine manufacturers once the preclinical data is ready. The WHO’s mRNA Technology Transfer Programme, developed in 2021, counts 15 countries, including Kenya, Nigeria and Ukraine, and their domestic partner manufacturers as members.

Why it matters: Global vaccine inequities marred the world’s Covid-19 response, leading to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article